205 related articles for article (PubMed ID: 3609485)
21. [Perioperative plasma antithrombin activity with "low-dose" heparin prophylaxis. Perioperatively acquired antithrombin III deficiency as a cause for the failure of heparin prophylaxis?].
Kussmann J; Hirche H; Sengupta R
Dtsch Med Wochenschr; 1983 Mar; 108(12):449-52. PubMed ID: 6832015
[TBL] [Abstract][Full Text] [Related]
22. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
[TBL] [Abstract][Full Text] [Related]
23. [The effect of antithrombin iii concentrations during cardiopulmonary surgery].
Sonzogni V; Bellavita P; Carrara B; Cossolini M; Ferri F; Fabretti F; Mamprin F; Pelliccioli I
Minerva Anestesiol; 2000; 66(1-2):17-23. PubMed ID: 10736978
[TBL] [Abstract][Full Text] [Related]
24. [Acquired antithrombin III deficiency].
Müller G
Z Gesamte Inn Med; 1992 Feb; 47(2):74-7. PubMed ID: 1585693
[TBL] [Abstract][Full Text] [Related]
25. Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome.
Vaziri ND; Paule P; Toohey J; Hung E; Alikhani S; Darwish R; Pahl MV
Arch Intern Med; 1984 Sep; 144(9):1802-3. PubMed ID: 6477000
[TBL] [Abstract][Full Text] [Related]
26. AT III Barcelona: a familial quantitative-qualitative AT III deficiency.
Grau E; Fontcuberta J; Félez J; de Diego I; Soto R; Rutllant ML
Thromb Haemost; 1988 Feb; 59(1):13-7. PubMed ID: 3363529
[TBL] [Abstract][Full Text] [Related]
27. [Management with antithrombin III concentrate in a pregnant woman with hereditary antithrombin III deficiency].
Higuchi M; Konya H; Tanaka H; Masuda H; Nishida Y; Koyama T; Suehiro A; Kakishita E; Ishita K
Rinsho Ketsueki; 1990 Sep; 31(9):1544-7. PubMed ID: 2246830
[TBL] [Abstract][Full Text] [Related]
28. Antithrombin III in Sepsis. New evidences and open questions.
Ostermann H
Minerva Anestesiol; 2002 May; 68(5):445-8. PubMed ID: 12029261
[TBL] [Abstract][Full Text] [Related]
29. Treatment of venous thromboembolism in patients with congenital deficiency of antithrombin III.
Schulman S; Tengborn L
Thromb Haemost; 1992 Dec; 68(6):634-6. PubMed ID: 1287876
[TBL] [Abstract][Full Text] [Related]
30. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
Levi M; Toh CH; Thachil J; Watson HG
Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
[TBL] [Abstract][Full Text] [Related]
31. Antithrombin III prophylaxis of venous thromboembolic disease after total hip or total knee replacement.
Francis CW; Pellegrini VD; Harris CM; Marder VJ
Am J Med; 1989 Sep; 87(3B):61S-66S. PubMed ID: 2478015
[TBL] [Abstract][Full Text] [Related]
32. [The clinical value of antithrombin III].
Vinazzer H; Bergmann H; Blauhut B
Wien Med Wochenschr; 1984 Jun; 134(12):279-83. PubMed ID: 6380122
[No Abstract] [Full Text] [Related]
33. The initial experience of antithrombin III in the management of neonates with necrotizing enterocolitis.
St Peter SD; Little DC; Calkins CM; Holcomb GW; Snyder CL; Ostlie DJ
J Pediatr Surg; 2007 Apr; 42(4):704-8. PubMed ID: 17448770
[TBL] [Abstract][Full Text] [Related]
34. The relative contributions of antithrombin III during heparin treatment, and of clinically recognisable risk factors, to early recurrence of venous thromboembolism.
Gallus AS; Goodall KT; Tillett J; Jackaman J; Wycherley A
Thromb Res; 1987 May; 46(4):539-53. PubMed ID: 3617012
[TBL] [Abstract][Full Text] [Related]
35. Antithrombin III-independent effect of depolymerized holothurian glycosaminoglycan (DHG) on acute thromboembolism in mice.
Nagase H; Kitazato KT; Sasaki E; Hattori M; Kitazato K; Saito H
Thromb Haemost; 1997 Feb; 77(2):399-402. PubMed ID: 9157603
[TBL] [Abstract][Full Text] [Related]
36. Oral anticoagulant therapy in venous thromboembolism.
Cosmi B; Palareti G
Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
[TBL] [Abstract][Full Text] [Related]
37. Antithrombin III deficiency: clinical aspects.
Nagy I
Haematologia (Budap); 1984; 17(1):87-91. PubMed ID: 6724356
[TBL] [Abstract][Full Text] [Related]
38.
Lu Z; Wang F; Liang M
Clin Sci (Lond); 2017 May; 131(9):823-831. PubMed ID: 28424376
[TBL] [Abstract][Full Text] [Related]
39. Substitution of antithrombin III.
Breddin HK; Kirchmaier CM
Wien Klin Wochenschr; 1984 Dec; 96(24):875-9. PubMed ID: 6528616
[TBL] [Abstract][Full Text] [Related]
40. On the clinical significance of acquired antithrombin deficiency.
Sørum Y; Handeland GF; Abildgaard U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):797-805. PubMed ID: 6083956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
